The Discovery Europe summit covers the latest advancements in target identification, validation and HIT optimization.
The event will bring together leading experts in the fields of Organoid Discovery, Phenotypic Screening, Targeted Protein Degradation, AI Computational Drug Design and Lead Optimization.
Thursday, June 9, 02:35 - 03:05 pm (CEST)
CRISPR Cell Line Development Revolutionized: Direct Intra-Nuclear Injection With FluidFM Enables Multi KO/KI And Exotic Cell Lines
Sensitive cells? Complex edits? We create the cell line for you.
Cytosurge provides you guaranteed monoclonal cell lines – even for hard-to-transfect and rare cells, complex edits like knock-ins with large repair templates, or multiple knock-outs.
During the presentation of Dr. Pablo Doerig, VP Research Solutions, you will learn more about our service enabled by our proprietary FluidFM® technology:
What is FluidFM and how can it be applied to cell line engineering
True single cell genome engineering: the power of the bottom-up approach
High quality monoclonal cell lines by reducing off-target editing and avoiding the tedious selection process
Customized design and consulting by our experts
Recent customer projects
Dr. Pablo Doerig, VP Research Solutions at Cytosurge